apollo
logo
0Login
Introducing Our Latest Arrival!
OBETOCAD-5MG TABLETS 10'S

OBETOCAD-5MG TABLETS 10'S

Prescription drug
 Trailing icon
Consult Doctor

Manufacturer/Marketer

Cadila Healthcare Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Jan-25

for this medicine

About OBETOCAD-5MG TABLETS

OBETOCAD-5MG TABLETS is used to treat primary biliary cirrhosis. Primary biliary cholangitis, also known as primary biliary cirrhosis, is an autoimmune disease caused by damage of bile ducts in the liver. Biliary cirrhosis causes a build-up of bile in the liver, which leads to liver damage.  
 
OBETOCAD-5MG TABLETS contains ‘Obeticholic acid’, which helps improve liver function by reducing the production and build-up of bile in the liver, increases the removal of bile from the liver, and reduces inflammation, thereby helping treat primary biliary cirrhosis.
 
Take OBETOCAD-5MG TABLETS as prescribed. In some cases, you may experience common side effects such as stomach pain, tiredness, dizziness, constipation, and palpitations. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if the side effects persist or worsen.
 
Consult your doctor if you are pregnant or breastfeeding. OBETOCAD-5MG TABLETS is not recommended for children and adolescents. OBETOCAD-5MG TABLETS may cause dizziness, so drive with caution. It is unknown if alcohol interacts with OBETOCAD-5MG TABLETS ; consult your doctor if you have any concerns. Keep your doctor informed about your health condition and medicines to rule out any side effects.

Uses of OBETOCAD-5MG TABLETS

Treatment of Primary biliary cirrhosis.

Medicinal Benefits

OBETOCAD-5MG TABLETS belongs to a group of medicines called farnesoid X-receptor agonists used to treat primary biliary cirrhosis/primary biliary cholangitis. OBETOCAD-5MG TABLETS helps improve liver function by reducing the production and build-up of bile in the liver and reduces inflammation, thereby helping treat primary biliary cirrhosis.

Directions for Use

Swallow OBETOCAD-5MG TABLETS as a whole with a glass of water; do not chew or crush it.

Storage

Store in a cool and dry place away from sunlight

Side Effects of OBETOCAD-5MG TABLETS

  • Stomach pain
  • Tiredness
  • Dizziness
  • Palpitations (irregular or fast heartbeat)
  • Constipation
  • Thyroid hormone irregularity

Drug Warnings

Do not take OBETOCAD-5MG TABLETS if you are allergic to any of its contents; if you have a complete blockage of the biliary tract (liver, bile ducts, and gall bladder). Inform your doctor if you experience itching that is difficult to tolerate. Consult your doctor if you are pregnant or breastfeeding. OBETOCAD-5MG TABLETS is not recommended for children or adolescents. OBETOCAD-5MG TABLETS may cause dizziness, so drive with caution. Consult a doctor immediately if you experience yellowing of the skin/eyes, black/tarry stools, dark urine, coughing up/vomiting blood, confusion, slurred speech, mood swings, anxiety, swelling in and around the stomach.

Drug Interactions

Drug-Drug Interactions: OBETOCAD-5MG TABLETS may interact with xanthines (theophylline), muscle relaxants (tizanidine), blood thinners (warfarin), bile acid sequestrants (cholestyramine, colestipol, colesevelam).

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interactions: Inform your doctor if you have biliary obstruction, liver impairment, or lipid disorder.

Drug-Drug Interactions Checker List

  • THEOPHYLLINE
  • TIZANIDINE
  • WARFARIN
  • CHOLESTYRAMINE
  • COLESTIPOL
  • COLESEVELAM

Habit Forming

No

Diet & Lifestyle Advise

  • Include foods such as bell peppers, citrus fruits, leafy vegetables, tomatoes, milk, fish, low-fat dairy, beans, nuts, lentils, tofu and tempeh.
  • Eat a healthy, well-balanced diet that includes fruits and vegetables.
  • Avoid high-fat, trans-fat, and processed foods.
  • White bread, white pasta and sugars should be avoided.
  • Avoid tobacco and alcohol consumption.

Special Advise

  • Regular blood tests for monitoring liver functioning are advised.

Disease/Condition Glossary

Primary biliary cholangitis: Primary biliary cholangitis, also known as primary biliary cirrhosis, is an autoimmune disease caused by damage to bile ducts in the liver. Bile ducts are the small channels that carry the bile (digestive fluid) from the liver to the small intestine, where it breaks down fats and aids in its absorption. Biliary cirrhosis causes a build-up of bile in the liver, which leads to liver damage. 

bannner image

Alcohol

Caution

It is not known if alcohol interacts with OBETOCAD-5MG TABLETS . Consult your doctor if you have any concerns.

bannner image

Pregnancy

Caution

Please consult your doctor if you are pregnant, as limited information is available regarding the usage of OBETOCAD-5MG TABLETS during pregnancy.

bannner image

Breast Feeding

Caution

Consult your doctor if you are breastfeeding; your doctor will decide whether OBETOCAD-5MG TABLETS can be taken by breastfeeding mothers or not.

bannner image

Driving

Safe if prescribed

OBETOCAD-5MG TABLETS does not affect your ability to drive. However, you are advised to omit driving if you experience dizziness.

bannner image

Liver

Caution

Dose adjustment may be needed. Please consult your doctor if you have a liver impairment or any concerns regarding this. Inform your doctor if you have/had liver cirrhosis.

bannner image

Kidney

Caution

Please consult your doctor if you have kidney impairment or any concerns regarding this.

bannner image

Children

Unsafe

OBETOCAD-5MG TABLETS is not recommended for children or adolescents.

Country of origin

India

Manufacturer/Marketer address

Sarkhej-Dholka Road, Bhat, Ahmedabad-382 210, INDIA.
Other Info - OBE0071

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

OBETOCAD-5MG TABLETS is used to treat primary biliary cirrhosis. Primary biliary cholangitis, also known as primary biliary cirrhosis, is an autoimmune disease caused by damage of bile ducts in the liver. Biliary cirrhosis causes a build-up of bile in the liver, which leads to liver damage.
OBETOCAD-5MG TABLETS helps improve liver functioning by reducing the production and build-up of bile in the liver and reduces inflammation.
Do not discontinue OBETOCAD-5MG TABLETS without consulting your doctor. To treat your condition effectually, continue taking OBETOCAD-5MG TABLETS for as long as prescribed. Do not be reluctant to speak with your doctor if you experience any difficulty while taking OBETOCAD-5MG TABLETS .
Constipation might be a side-effect of OBETOCAD-5MG TABLETS . Drink lots of fluids and eat fibre-rich food if you experience constipation. Talk to your doctor if you have severe constipation.
Consult your doctor before taking OBETOCAD-5MG TABLETS along with bile acid-binding resins, as they might lower the effect of OBETOCAD-5MG TABLETS . If prescribed, maintain a gap of 4-6hours between OBETOCAD-5MG TABLETS and bile acid-binding resins. Bile acid-binding resins are used to lower blood cholesterol levels.
OBETOCAD-5MG TABLETS may cause palpitation, a sensation that the heart is racing, pounding, or fluttering. A minor fluctuation should not be a worry; however, if palpitations continue or you begin to feel unwell, speak with your doctor.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.